Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Cash from Investing Activities: 2015-2019

Historic Cash from Investing Activities for Outlook Therapeutics (OTLK) over the last 5 years, with Sep 2019 value amounting to -$1.

  • Outlook Therapeutics' Cash from Investing Activities rose 100.00% to -$1 in Q3 2019 from the same period last year, while for Sep 2019 it was -$437,307, marking a year-over-year increase of 84.28%. This contributed to the annual value of -$900,000 for FY2020, which is 105.81% down from last year.
  • Latest data reveals that Outlook Therapeutics reported Cash from Investing Activities of -$1 as of Q3 2019, which was up 100.00% from -$150,737 recorded in Q2 2019.
  • Outlook Therapeutics' Cash from Investing Activities' 5-year high stood at $46,949 during Q1 2016, with a 5-year trough of -$3.5 million in Q2 2015.
  • In the last 3 years, Outlook Therapeutics' Cash from Investing Activities had a median value of -$150,737 in 2019 and averaged -$305,651.
  • As far as peak fluctuations go, Outlook Therapeutics' Cash from Investing Activities slumped by 5,165.95% in 2018, and later spiked by 100.00% in 2019.
  • Outlook Therapeutics' Cash from Investing Activities (Quarterly) stood at -$364,242 in 2015, then skyrocketed by 59.27% to -$148,362 in 2016, then plummeted by 624.68% to -$1.1 million in 2017, then surged by 78.01% to -$236,433 in 2018, then spiked by 100.00% to -$1 in 2019.
  • Its Cash from Investing Activities stands at -$1 for Q3 2019, versus -$150,737 for Q2 2019 and -$50,136 for Q1 2019.